当前位置: X-MOL 学术Sci. Immunol › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ILC2s—Bipartisan politicians in cancer
Science Immunology ( IF 24.8 ) Pub Date : 2022-06-03 , DOI: 10.1126/sciimmunol.abq2791
Abderezak Zebboudj 1, 2 , Masataka Amisaki 1, 2 , Vinod P Balachandran 1, 2, 3, 4
Affiliation  

Group 2 innate lymphoid cells (ILC2s) are lymphocytes that both promote and suppress antitumor immunity. Jou and colleagues now report in colorectal tumorigenesis that the cytokine interleukin-25 activates ILC2s to induce myeloid cells that suppress antitumor immunity.

中文翻译:

ILC2s——癌症领域的两党政客

第 2 组先天性淋巴样细胞 (ILC2) 是既能促进又能抑制抗肿瘤免疫的淋巴细胞。Jou 及其同事现在在结直肠肿瘤发生中报告说,细胞因子白介素 25 激活 ILC2 以诱导抑制抗肿瘤免疫的骨髓细胞。
更新日期:2022-06-03
down
wechat
bug